Related Experiment Video
Updated: Dec 29, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference
Silke Gillessen1, Gerhardt Attard2, Tomasz M Beer3
1Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK.
The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 results offer expert guidance on managing advanced prostate cancer where evidence is limited. These findings aid clinicians and patients in navigating complex treatment decisions for better outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Advances in treatments, imaging, and molecular characterization have improved outcomes in advanced prostate cancer.
- Significant gaps in high-level evidence remain, impacting clinical practice for complex management aspects.
Framework:
- The Advanced Prostate Cancer Consensus Conference (APCCC) 2019 convened 72 international experts to address 10 controversial areas in advanced prostate cancer management.
- A modified Delphi process was used to develop 123 consensus questions, covering topics from locally advanced disease to managing treatment side effects.
Implementation:
- Experts anonymously voted on predefined questions, reflecting their opinions rather than formal literature reviews.
- Results indicate varying levels of expert support for different management approaches, detailed in supplementary materials.
Implications:
- The APCCC 2019 voting results provide a practical guide for clinicians and patients facing limited evidence in advanced prostate cancer management.
- Individualized treatment decisions, clinical trial enrollment, and further research are crucial for advancing care and improving patient outcomes.
Related Concept Videos
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers

